I agree that this site is using cookies. You can find further informations here.
X
Tmoyan, N.A.
46  results:
Search for persons X
?
1

Association of lipoprotein(a) with coronary artery disease ..:

Tmoyan, N.A. ; Ezhov, M.V. ; Afanasieva, O.I....
Atherosclerosis.  355 (2022)  - p. 40-41 , 2022
Link: https://doi.org/10.1016/..
 
?
2

Hyperlipoproteinemia(a) is related to severe coronary and c..:

Chubykina, U.V. ; Afanasieva, O.I. ; Klesareva, E.A...
Atherosclerosis.  355 (2022)  - p. 55-56 , 2022
Link: https://doi.org/10.1016/..
 
?
3

Hyperlipoproteinemia(a) in familial hypercholesterolemia:

Chubykina, U.V. ; Bliznyuk, S.A. ; Afanasieva, M.I..
Atherosclerosis.  331 (2021)  - p. e117 , 2021
Link: https://doi.org/10.1016/..
 
?
4

Elevated lipoprotein(a) as a predictor for multivessel dise..:

Chubykina, U.V. ; Klesareva, E.A. ; Tmoyan, N.A.
Atherosclerosis.  331 (2021)  - p. e55 , 2021
Link: https://doi.org/10.1016/..
 
?
5

Elevated lipoprotein(a) level predicts repeated peripheral ..:

Tmoyan, N ; Ezhov, M ; Afanasieva, O...
European Heart Journal.  42 (2021)  Supplement_1 - p. , 2021
Link: https://doi.org/10.1093/..
 
?
6

Lipoprotein(a) and inflammatory markers in polyvascular ath..:

Tmoyan, N.A. ; Klesareva, E.A. ; Tyurina, A.V....
Atherosclerosis.  331 (2021)  - p. e36 , 2021
Link: https://doi.org/10.1016/..
 
?
7

Efficacy of hyperlipoproteinemia(a) cascade screening in FH..:

Chubykina, U.V. ; Klesareva, E.A. ; Tmoyan, N.A.
Atherosclerosis.  331 (2021)  - p. e116-e117 , 2021
Link: https://doi.org/10.1016/..
 
?
8

Elevated lipoprotein(A) level influences on familial hyperc..:

Chubykina, U.V. ; Ezhov, M.V. ; Tmoyan, N.A....
Atherosclerosis.  315 (2020)  - p. e33-e34 , 2020
Link: https://doi.org/10.1016/..
 
?
9

Predictors of cardiovascular outcomes in patients with hete..:

Bliznyuk, S.A. ; Rozhkova, T.A. ; Ezhov, M.V....
Atherosclerosis.  315 (2020)  - p. e193-e194 , 2020
Link: https://doi.org/10.1016/..
 
?
10

Role of lipoprotein(a) and its autoantibodies in polyvascul..:

Tmoyan, N ; Afanasieva, O ; Ezhov, M...
European Heart Journal.  41 (2020)  Supplement_2 - p. , 2020
Link: https://doi.org/10.1093/..
 
?
11

Adherence and efficiency of lipid-lowering therapy in patie..:

Ezhov, M.V. ; Tmoyan, N.A. ; Rozhkova, T.A....
Atherosclerosis.  315 (2020)  - p. e43 , 2020
Link: https://doi.org/10.1016/..
 
?
12

Lipoprotein(a) as an independent factor associated with int..:

Tmoyan, N.A. ; Ezhov, M.V. ; Afanasieva, O.I....
Atherosclerosis.  315 (2020)  - p. e145-e146 , 2020
Link: https://doi.org/10.1016/..
 
?
13

P2748Lipoprotein(a) and autotaxin in patients with stenotic..:

Afanasieva, O ; Tmoyan, N ; Razova, O...
European Heart Journal.  40 (2019)  Supplement_1 - p. , 2019
Link: https://doi.org/10.1093/..
 
?
14

P5292Obesity paradox, hyperlipoproteinemia(a), autotaxin co..:

Afanasieva, O ; Tmoyan, N ; Razova, O...
European Heart Journal.  40 (2019)  Supplement_1 - p. , 2019
Link: https://doi.org/10.1093/..
 
?
15

Lipoprotein(A) Level And Autoantibodies To It In Patients W..:

Tmoyan, N. ; Ezhov, M. ; Afanasieva, O....
Atherosclerosis.  287 (2019)  - p. e229 , 2019
Link: https://doi.org/10.1016/..
 
1-15